SCHEMBL6199738

SCHEMBL6199738

CN(C)c1ccc(NC(=O)Nc2cccc(-c3c(Cl)cnn3C)c2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.64
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
MAPT P10636 2/20 0.58
MEN1 O00255 1/20 0.58
LMNA P02545 1/20 0.58
TP53 P04637 1/20 0.58
TSHR P16473 1/20 0.58
NFKB1 P19838 1/20 0.58
NFKB2 Q00653 1/20 0.58
KMT2A Q03164 1/20 0.58
RELA Q04206 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
NOX1 Q9Y5S8 1/20 0.58
HTR2C P28335 3/20 0.53
CNR1 P21554 10/20 0.52
BAZ1A Q9NRL2 1/20 0.48
CNR2 P34972 2/20 0.47
PNPLA2 Q96AD5 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6201643 0.89 HTR2A (0.79) HTR2AHTR2CCNR1CNR2
SCHEMBL6200786 0.87 HTR2A (0.77) HTR2ANPC1RAB9AMAPTMEN1
SCHEMBL6201386 0.86 HTR2A (0.68) HTR2AMAPTHTR2CCNR1CNR2
SCHEMBL6198676 0.85 HTR2A (0.64) HTR2AMAPTMEN1TP53KMT2A
SCHEMBL6198462 0.84 HTR2A (0.62) HTR2AMAPTMEN1LMNATSHR
SCHEMBL6196200 0.83 HTR2A (0.65) HTR2ANPC1RAB9AMAPTMEN1
SCHEMBL6195174 0.82 HTR2A (0.60) HTR2ANPC1RAB9AMAPTMEN1
SCHEMBL6200665 0.82 HTR2A (0.57) HTR2ANPC1RAB9AMAPTSMN1; SMN2
SCHEMBL6198156 0.81 TRPV1 (0.62) HTR2ANPC1RAB9AMAPTMEN1
SCHEMBL6199415 0.80 HTR2A (0.64) HTR2ANPC1RAB9AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1509505-A2 SMALL MOLECULE MODULATORS OF THE 5−HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2005-03-02 EP claimed
WO-2003062206-A2 SMALL MOLECULE MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2003-07-31 WO claimed